These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 25203086)

  • 1. Ten-year follow-up after initiation of statin therapy in children with familial hypercholesterolemia.
    Kusters DM; Avis HJ; de Groot E; Wijburg FA; Kastelein JJ; Wiegman A; Hutten BA
    JAMA; 2014 Sep; 312(10):1055-7. PubMed ID: 25203086
    [No Abstract]   [Full Text] [Related]  

  • 2. Lipoprotein-associated phospholipase A2 mass and activity in children with heterozygous familial hypercholesterolemia and unaffected siblings: effect of pravastatin.
    Ryu SK; Hutten BA; Vissers MN; Wiegman A; Kastelein JJ; Tsimikas S
    J Clin Lipidol; 2011; 5(1):50-6. PubMed ID: 21262507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized controlled trial.
    Wiegman A; Hutten BA; de Groot E; Rodenburg J; Bakker HD; Büller HR; Sijbrands EJ; Kastelein JJ
    JAMA; 2004 Jul; 292(3):331-7. PubMed ID: 15265847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statin treatment in children with familial hypercholesterolemia: the younger, the better.
    Rodenburg J; Vissers MN; Wiegman A; van Trotsenburg AS; van der Graaf A; de Groot E; Wijburg FA; Kastelein JJ; Hutten BA
    Circulation; 2007 Aug; 116(6):664-8. PubMed ID: 17664376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 20-Year Follow-up of Statins in Children with Familial Hypercholesterolemia.
    Luirink IK; Wiegman A; Kusters DM; Hof MH; Groothoff JW; de Groot E; Kastelein JJP; Hutten BA
    N Engl J Med; 2019 Oct; 381(16):1547-1556. PubMed ID: 31618540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early initiation of statin treatment in children with familial hypercholesterolaemia.
    Braamskamp MJ; Hutten BA; Wiegman A
    Curr Opin Lipidol; 2015 Jun; 26(3):236-9. PubMed ID: 25943840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-density lipoprotein receptor genotype and response to pravastatin in children with familial hypercholesterolemia: substudy of an intima-media thickness trial.
    Koeijvoets KC; Rodenburg J; Hutten BA; Wiegman A; Kastelein JJ; Sijbrands EJ
    Circulation; 2005 Nov; 112(20):3168-73. PubMed ID: 16286607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gonadal steroids, gonadotropins and DHEAS in young adults with familial hypercholesterolemia who had initiated statin therapy in childhood.
    Braamskamp MJ; Kusters DM; Wiegman A; Avis HJ; Wijburg FA; Kastelein JJ; van Trotsenburg AS; Hutten BA
    Atherosclerosis; 2015 Aug; 241(2):427-32. PubMed ID: 26079405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statin therapy and secretory phospholipase A₂ in children with heterozygous familial hypercholesterolemia.
    Braamskamp MJ; Tsimikas S; Wiegman A; Kastelein JJ; Hutten BA
    Atherosclerosis; 2013 Aug; 229(2):404-7. PubMed ID: 23880195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Protective effects of pravastatin against atherosclerosis in children with familial hypercholesterolemia].
    Riesen WF
    Rev Med Suisse; 2005 Mar; 1(9):649. PubMed ID: 15813344
    [No Abstract]   [Full Text] [Related]  

  • 11. The spectrum of statin therapy in hyperlipidemic children.
    Rodenburg J; Vissers MN; Trip MD; Wiegman A; Bakker HD; Kastelein JJ
    Semin Vasc Med; 2004 Nov; 4(4):313-20. PubMed ID: 15861313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statin Initiation During Childhood in Patients With Familial Hypercholesterolemia: Consequences for Cardiovascular Risk.
    Braamskamp MJAM; Kastelein JJP; Kusters DM; Hutten BA; Wiegman A
    J Am Coll Cardiol; 2016 Feb; 67(4):455-456. PubMed ID: 26821635
    [No Abstract]   [Full Text] [Related]  

  • 13. [After several years of statin therapy. Long-term prevention of cardiac death].
    MMW Fortschr Med; 2003 Feb; 145(8):56. PubMed ID: 12661448
    [No Abstract]   [Full Text] [Related]  

  • 14. Oxidized low-density lipoprotein in children with familial hypercholesterolemia and unaffected siblings: effect of pravastatin.
    Rodenburg J; Vissers MN; Wiegman A; Miller ER; Ridker PM; Witztum JL; Kastelein JJ; Tsimikas S
    J Am Coll Cardiol; 2006 May; 47(9):1803-10. PubMed ID: 16682304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose statin therapy does not induce insulin resistance in patients with familial hypercholesterolemia.
    Panz V; Immelman A; Paiker J; Pilcher G; Raal F
    Metab Syndr Relat Disord; 2012 Oct; 10(5):351-7. PubMed ID: 22816732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term follow-up of statin treatment in a cohort of children with familial hypercholesterolemia: efficacy and tolerability.
    Carreau V; Girardet JP; Bruckert E
    Paediatr Drugs; 2011 Aug; 13(4):267-75. PubMed ID: 21692550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of pravastatin in children and adolescents with heterozygous familial hypercholesterolemia: a prospective clinical follow-up study.
    Hedman M; Matikainen T; Föhr A; Lappi M; Piippo S; Nuutinen M; Antikainen M
    J Clin Endocrinol Metab; 2005 Apr; 90(4):1942-52. PubMed ID: 15657370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of CS-514, a new inhibitor of HMG CoA reductase, on plasma lipids, lipoproteins and apoproteins in patients with primary hypercholesterolemia.
    Kazumi T; Yoshino G; Kasama T; Iwatani I; Iwai M; Morita S; Baba S
    Horm Metab Res; 1986 Sep; 18(9):654-5. PubMed ID: 3096862
    [No Abstract]   [Full Text] [Related]  

  • 19. Carotid atherosclerosis progression in familial hypercholesterolemia patients: a pooled analysis of the ASAP, ENHANCE, RADIANCE 1, and CAPTIVATE studies.
    Vergeer M; Zhou R; Bots ML; Duivenvoorden R; Koglin J; Akdim F; Mitchel YB; Huijgen R; Sapre A; de Groot E; Sijbrands EJ; Pasternak RC; Gagné C; Marais AD; Ballantyne CM; Isaacsohn JL; Stalenhoef AF; Kastelein JJ
    Circ Cardiovasc Imaging; 2010 Jul; 3(4):398-404. PubMed ID: 20494942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of hydroxymethylglutaryl-CoA reductase inhibitors on the functional properties of erythrocyte membranes.
    Rabini RA; Polenta M; Staffolani R; Tocchini M; Signore R; Testa I; Mazzanti L
    Exp Mol Pathol; 1993 Aug; 59(1):51-7. PubMed ID: 8262165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.